Sherry L. Bouse
FDA investigator
Appears on 1 document from 2013, mostly at sites in Kansas. Most often cites production record review (21 CFR 211.192).
- 1
- Documents on file
- 5.0
- Observations per 483
- 2013
- First seen
- 2013
- Most recent
What they cite most
From 7 observations- 21 CFR 211.192Production record review3
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.160General requirements1
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
Activity by year
2013: 1
Where
Kansas 1
Often inspects with
Is Sherry L. Bouse coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2013-10-09 | 483 Meridian Medical Technologies, Inc.Oct 9, 2013 · Saint Louis, Kansas | Saint Louis, Kansas | 5 |
About this profile
What does Sherry L. Bouse inspect?
Sherry L. Bouse appears on 1 document on file covering 1 site, mostly in Kansas.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Sherry L. Bouse is dated Oct 9, 2013.